Placeholder Banner

BIO International Convention Opens in Boston, Showcasing Global Innovation in Biotechnology

June 16, 2025

The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanity

BOSTON (June 16, 2025) The BIO International Convention, the world’s largest and most comprehensive event for the biotechnology industry, opens today in Boston. It will convene more than 20,000 biotech and life sciences leaders from around the globe.

Spanning four days, the convention features more than 180 sessions and 1100 speakers across 20 focus areas — from AI and digital health to next-generation biotherapeutics, business development, and more. Participants include leading biotech companies, investors, service providers, government officials, regulators, and patient advocates, representing the full ecosystem of biotechnology, from startups and academic institutions to established pharmaceutical leaders and global policymakers.

BIO International is the premier hub for deal-making, with more than 10,000+ partnering delegates and 60,000+ partnering meetings expected to take place during the event. 

Key sessions will explore:

  • AI and Machine Learning in Drug Discovery
  • Next-Generation Cell and Gene Therapies
  • Public Policy and Global Regulation
  • Investment Trends in Biotech
  • Patient-Centered Innovation

The broad lineup of notable speakers includes President George W. Bush; FDA Commissioner Martin A. Makary, M.D., M.P.H.; Massachusetts Governor Maura Healey; Pennsylvania Governor Josh Shapiro; Olivér Várhelyi, European Commissioner for Health and Animal Welfare; Lord Vallance, UK Minister of State for Science, Research and Innovation; H.E. Prof. Dr. Hisham Saad Aljadhey, CEO, Saudi Food and Drug Authority; Dr. Angela Belcher, National Security Commission on Emerging Biotechnology;  Dr. Michelle Rozo, National Security Commission on Emerging Biotechnology; and Pro Football Hall of Famer, Broadcaster, and Entrepreneur, Michael Strahan. 

This year, the convention will feature the BIO Storytelling Stage, a new space on the exhibition floor dedicated to the human side of biotech. Through film screenings, live conversations, and curated storytelling, this stage will spotlight the personal journeys that define the industry’s heart and impact. 

“Biotechnology is driven by collaboration, and there is no greater place in the world for industry, stakeholder, and advocate partnership than the BIO International Convention,” said John F. Crowley, President & CEO of BIO. “Here, innovators, scientists, patients, and investors come together to turn small ideas into life-saving solutions, and at a time when the world needs big breakthroughs, BIO’s convention is poised to meet the moment and help deliver better, longer lives for people in the U.S. and around the world.”

Quick Stats:

Registrants: 20,000+ (46% international)

Countries represented: 72 

Exhibitors: 1,600

Sessions: 180+

Speakers: 1,100+

Partnering meetings: 60,000+ 

Partnering delegates: 10,000+

 

###

 

About BIO

BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org. 

Discover More
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthWASHINGTON (November 10, 2026) - The Biotechnology Innovation…
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.WASHINGTON, DC & SAN DIEGO, CA & SAN FRANCISCO, CA - The…
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact…